XTRX.CN Adastra (CNQ) volume 8,066 on 04 Feb 2026: watch CAD 0.21

A volume spike drove Adastra Holdings Ltd. (XTRX.CN) trading on the CNQ during market hours on 04 Feb 2026, with 8,066 shares traded versus an average of 291. XTRX.CN stock opened at CAD 0.26, printed an intraday high of CAD 0.26 and closed near CAD 0.21, a -2.33% move. The surge follows the company’s recent earnings announcement on 27 Jan 2026 and pushed relative volume to 27.72x the average, flagging this as a volume-spike setup worth watching for short-term entry or defensive trimming.

Volume spike and immediate price action for XTRX.CN stock

Adastra’s trading volume jumped to 8,066 shares today, well above the 50-day average of 291, producing a relative volume of 27.72. That spike occurred during market hours and coincided with heightened order flow after the 27 Jan 2026 earnings announcement.

Price action is clustered between CAD 0.21 and CAD 0.26 today. The intraday range and the volume surge suggest short-term liquidity returned to the stock, creating clearer support at CAD 0.21 and initial resistance at CAD 0.26.

Fundamentals and ratios driving XTRX.CN stock momentum

Adastra reports EPS of -2.59 and a trailing PE of -0.08, reflecting negative earnings but a small market cap of CAD 1.18M. Key ratios show low liquidity with a current ratio of 0.38 and negative book value per share of -0.17. These metrics explain elevated risk despite revenue per share of 3.01.

Sector context matters: the Canadian Healthcare group has average PE roughly 14.24, so XTRX.CN stock trades well below sector valuation. Investors should weigh the company’s specialty extraction services against these stretched fundamentals.

Technical indicators and short-term targets for XTRX.CN stock

Momentum tools are mixed: RSI at 56.16 suggests mild strength while ADX at 33.22 indicates a strong short-term trend. Bollinger Bands sit 0.19/0.24/0.29, which frames volatility and potential squeeze breakout levels. The 50-day average is CAD 0.23 and the 200-day average is CAD 0.25.

Technically, immediate support is CAD 0.21 and resistance near CAD 0.26. A confirmed move above CAD 0.26 on rising volume could target CAD 0.40 as the next tactical level, with a stretch target at CAD 0.71 per model scenarios.

Meyka AI grading and model forecast for XTRX.CN stock

Meyka AI rates XTRX.CN with a score of 63.39 out of 100 (Grade: B, Suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects a monthly price of CAD 0.32 and a quarterly price of CAD 0.71. Compared with the current price of CAD 0.21, that implies near-term upside of 52.38% to the monthly model and 238.10% to the quarterly model. Forecasts are model-based projections and not guarantees.

Catalysts, risks and sector comparison for XTRX.CN stock

Catalysts include contract wins with licensed cultivators, stronger extract demand, or follow-up operational updates after the 27 Jan 2026 results. Sector headwinds include tighter capital access for small cannabis processors and broader Healthcare volatility.

Key risks are limited liquidity, negative EPS, weak current ratio, and high working capital demands. Relative to the Healthcare sector averages, Adastra carries higher operational risk but lower market valuation, creating opportunity only for risk-tolerant investors.

Trading strategy and execution on the volume spike for XTRX.CN stock

For traders, the volume spike creates two clear plays: a momentum entry above CAD 0.26 with stop under CAD 0.21, or a mean-reversion approach buying near support CAD 0.21 with tight risk controls. Use position sizing that accounts for low liquidity and a market cap of CAD 1.18M.

Longer-term investors should demand operational improvement, clearer cash flow signs, or industry contracts before adding size. Volatility and the company’s negative cash flow ratios mean a conservative allocation is prudent.

Final Thoughts

The volume spike on 04 Feb 2026 makes XTRX.CN stock the focus for active traders today; 8,066 shares traded versus an average of 291, and price consolidated at CAD 0.21. Technically, a break above CAD 0.26 on continued volume opens a near-term target of CAD 0.40 and aligns with Meyka AI’s monthly forecast of CAD 0.32 and quarterly forecast of CAD 0.71. Fundamental risks remain: negative EPS of -2.59, a low current ratio of 0.38, and a tiny market cap around CAD 1.18M. Meyka AI’s grade (B, HOLD) reflects mixed signals: potential upside from model forecasts but elevated financial risk. Traders seeking short-term moves can watch support at CAD 0.21 and size positions tightly; longer-term investors should wait for cash-flow improvement or clearer contract news. Forecasts are model-based projections and not guarantees, and we recommend confirming liquidity before executing larger trades. Meyka AI — our AI-powered market analysis platform — will monitor volume and price for updates

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.